Observational studyImmunotherapy2025

Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations.

Matilde Corianò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.